- Home
- CTNM vs RBB Comparison
CTNM vs RBB Comparison
Compare CTNM & RBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- RBB
- Stock Information
- Founded
- CTNM 2009
- RBB 2008
- Country
- CTNM United States
- RBB United States
- Employees
- CTNM N/A
- RBB N/A
- Industry
- CTNM
- RBB Major Banks
- Sector
- CTNM
- RBB Finance
- Exchange
- CTNM Nasdaq
- RBB Nasdaq
- Market Cap
- CTNM 453.0M
- RBB 415.0M
- IPO Year
- CTNM 2024
- RBB 2017
- Fundamental
- Price
- CTNM $16.48
- RBB $24.43
- Analyst Decision
- CTNM Strong Buy
- RBB Hold
- Analyst Count
- CTNM 3
- RBB 5
- Target Price
- CTNM $28.67
- RBB $19.30
- AVG Volume (30 Days)
- CTNM 103.0K
- RBB 48.8K
- Earning Date
- CTNM 11-16-2024
- RBB 10-21-2024
- Dividend Yield
- CTNM N/A
- RBB 2.64%
- EPS Growth
- CTNM N/A
- RBB N/A
- EPS
- CTNM N/A
- RBB 1.91
- Revenue
- CTNM N/A
- RBB $117,599,000.00
- Revenue This Year
- CTNM N/A
- RBB N/A
- Revenue Next Year
- CTNM N/A
- RBB $4.96
- P/E Ratio
- CTNM N/A
- RBB $12.68
- Revenue Growth
- CTNM N/A
- RBB N/A
- 52 Week Low
- CTNM $13.27
- RBB $11.15
- 52 Week High
- CTNM $22.00
- RBB $24.50
- Technical
- Relative Strength Index (RSI)
- CTNM N/A
- RBB 70.43
- Support Level
- CTNM N/A
- RBB $22.46
- Resistance Level
- CTNM N/A
- RBB $22.96
- Average True Range (ATR)
- CTNM 0.00
- RBB 0.45
- MACD
- CTNM 0.00
- RBB 0.18
- Stochastic Oscillator
- CTNM 0.00
- RBB 97.63
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About RBB RBB Bancorp
RBB Bancorp operates as a bank holding company. It provides various banking products and services such as checking, savings, money market accounts, and certificates of deposits. Its Specific services include remote deposit, E-banking, mobile banking, commercial and investor real estate loans, business loans and lines of credit, Small Business Administration (SBA) 7A and 504 loans, mortgage loans, trade finance, and a full range of depository accounts. It generates its revenue from interest received on loans and leases and, to a lesser extent, from interest received on investment securities and derives income from noninterest sources, such as fees received in connection with various lending and deposit services, loan servicing, gain on sales of loans, and wealth management services.